Global Infectious Disease Rapid Diagnostic Testing Market

      2.1   Scope of Work
      2.2   Key Questions Answered in the Report

      3.1   Primary Data Sources
      3.2   Secondary Data Sources
      3.3   Market Estimation Model

      4.1   Definitions
              4.1.1   Market Definition
              4.1.2   Definition by Products
                         4.1.2.1   Platforms
                         4.1.2.2   Assays
      4.2   Infectious Disease Rapid Diagnostic Technologies
      4.3   Situation Analysis: Pre-COVID Vs. Post-COVID
      4.4   Impact of COVID-19 on Infectious Disease Rapid Diagnostic Testing
              4.4.1   Impact of COVID-19 on Different Countries
      4.5   Market Size and Growth Potential, $Million, 2019-2025
              4.5.1   Overview
              4.5.2   Most Promising Countries in the Infectious Disease Rapid Diagnostic Testing Market
                         4.5.2.1   U.S.
                         4.5.2.2   Italy
                         4.5.2.3   China
                         4.5.2.4   India
                         4.5.2.5   Brazil
                         4.5.2.6   Kingdom of Saudi Arabia (K.S.A.)
                         4.5.2.7   Democratic Republic of Congo

      5.1   Overview
      5.2   Impact Analysis
      5.3   Drivers
              5.3.1   Rising Incidence of Frequent Pandemics, such as COVID-19 Infectious Disease, Inciting the Development of Rapid Diagnostic Assays
              5.3.2   Significant Innovation Resulting in Market Pull
              5.3.3   Shift from Centralized to Decentralized Laboratories
              5.3.4   Significant External Funding for Executing R&D Exercises
      5.4   Restraints
              5.4.1   Lack of Standard Regulatory Processes
              5.4.2   Shortage of Skilled Professionals and Trained Lab-Technicians
              5.4.3   Less Efficiency of Rapid Diagnostic Testing as Compared with that of Laboratory Testing
      5.5   Opportunities
              5.5.1 Development of Infectious Disease Diagnostic Assays for Various Clinical Areas

      6.1   Overview
      6.2   Assays
      6.3   Platforms

      7.1   Overview
      7.2   Real-Time PCR (q-PCR)
      7.3   Isothermal Nucleic Acid Amplification Technology (INAAT)
      7.4   Lateral Flow Immunoassay (LFIA)
      7.5   Enzyme Immunoassay (EIA)
      7.6   Others

      8.1   Overview
      8.2   Respiratory Infection
      8.3   Gastro-Intestinal Infection
      8.4   Center Nervous System Infection
      8.5   Hospital Acquired Infection
      8.6   Sexually Transmitted Infections
      8.7   Others

      9.1   Overview
      9.2   Bacterial Infection
              9.2.1   Hospital Acquired Infections
              9.2.2   Tuberculosis
              9.2.3   CT/NG
              9.2.4   Others
      9.3   Viral Infections
              9.3.1   Influenza Virus
              9.3.2   Hepatitis
              9.3.3   HIV-AIDS
              9.3.4   HPV
              9.3.5   Others
      9.4   Other Infections

        10.1   XCR Diagnostics, Inc.
        10.2   Co-Diagnostics Inc.
        10.3   Inflammatix, Inc.
        10.4   DNA Electronics
        10.5   Mylab Discovery Solutions Pvt. Ltd.
        10.6   CerTest BIOTEC S.L.

        11.1   Overview
        11.2   North America
                  11.2.1   U.S
                  11.2.2   Canada
        11.3   Europe
                  11.3.1   Germany
                  11.3.2   U.K.
                  11.3.3   France
                  11.3.4   Italy
                  11.3.5   Spain
                  11.3.6   Russia
                  11.3.7   Rest-of-Europe
         11.4   Asia-Pacific
                  11.4.1   China
                  11.4.2   Japan
                  11.4.3   India
                  11.4.4   Taiwan
                  11.4.5   South Korea
                  11.4.6   Singapore
                  11.4.7   Australia
                  11.4.8   Rest-of-APAC
         11.5   Latin America
                  11.5.1   Brazil
                  11.5.2   Mexico
                  11.5.3   Rest-of-Latin America
        11.6   Middle East
        11.7   Africa
        11.8   Rest-of-the-World (RoW)

        12.1   Overview
        12.2   Hospitals
        12.3   Clinics
        12.4   Diagnostic Centers
        12.5   Other End Users

        13.1   Key Strategies and Developments
                  13.1.1   Product Approvals
                  13.1.2   Product Launches and Upgradations
                  13.1.3   Synergistic Activities
                  13.1.4   Funding and Expansion
                  13.1.5   Mergers and Acquisitions
        13.2   Industry Trends
        13.3   Market Share Analysis (by Company), 2019
        13.4   Growth Share Analysis (Opportunity Mapping)
                  13.4.1   By Company
                  13.4.2   By Application
                  13.4.3   By Technology

        14.1   Overview
        14.2   Abbott Laboratories
                  14.2.1   Company Overview
                  14.2.2   BIS Insights
        14.3   F. Hoffmann-La Roche Ltd
                  14.3.1   Company Overview
                  14.3.2   BIS Insights
        14.4   Danaher Corporation
                  14.4.1   Company Overview
                  14.4.2   BIS Insights
        14.5   Luminex Corporation
                  14.5.1   Company Overview
                  14.5.2   BIS Insights
        14.6   BGI Group
                  14.6.1   Company Overview
                  14.6.2   BIS Insights
        14.7   bioMérieux S.A.
                  14.7.1   Company Overview
                  14.7.2   BIS Insights
        14.8   DiaSorin S.p.A
                  14.8.1   Company Overview
                  14.8.2   BIS Insights
        14.9   Hologic, Inc.
                  14.9.1   Company Overview
                  14.9.2   BIS Insights
      14.10   Mesa Biotech
                  14.10.1   Company Overview
                  14.10.2   BIS Insights
      14.11   Quidel Corporation
                  14.11.1   Company Overview
                  14.11.2   BIS Insights
      14.12   Thermo Fisher Scientific Inc.
                  14.12.1   Company Overview
                  14.12.2   BIS Insights
      14.13   GenMark Diagnostics
                  14.13.1   Company Overview
                  14.13.2   BIS Insights
      14.14   CTK Biotech
                  14.14.1   Company Overview
                  14.14.2   BIS Insights
      14.15   Becton, Dickinson and Company
                  14.15.1   Company Overview
                  14.15.2   BIS Insights
      14.16   Cellex
                  14.16.1   Company Overview
                  14.16.2   BIS Insights

Table 5.1:    Impact Analysis of Market Drivers
Table 5.2:    Impact Analysis of Market Restraints
Table 6.1:    Key Rapid Diagnostic Assays Offered for Infectious Disease
Table 6.2:    Key Platforms Offered for Infectious Disease
Table 7.1:    Key Products Offered Based on RT-PCR
Table 7.2:    Key Products Offered Based on INAAT
Table 7.3:    Key Products Offered Based on LFIA
Table 7.4:    Key Products Offered Based on EIA
Table 7.5:    Key Products Offered Based on Other Technologies
Table 8.1:    Key Products Offered for COVID-19 Diagnosis
Table 8.2:    Key Products Offered for Respiratory Infection Diagnosis
Table 8.3:    Key Products Offered for Gastro-Intestinal Infection
Table 8.4:    Key Products Offered for Center Nervous System Infection
Table 8.5:    Key Products Offered for Hospital-Acquired Infections
Table 8.6:    Key Products Offered for Sexually Transmitted Infections
Table 8.7:    Key Products Offered for Other Applications

Figure 1:    Number of COVID-19 Cases in Severely Affected Countries, as of April 8, 2020
Figure 2:    Impact Analysis of Market Drivers and Market Challenges on the Global Infectious Disease Rapid Diagnostic Testing Market
Figure 3:    Global Infectious Disease Rapid Diagnostic Testing Market (by Product),  2019 Vs. 2025, $Million
Figure 4:    Global Infectious Disease Rapid Diagnostic Testing Market (by Technology), 2019 Vs. 2025, $Million
Figure 5:    Global Infectious Disease Rapid Diagnostic Testing Market (by Disease Pathogen), 2019 Vs. 2025, $Million
Figure 6:    Global Infectious Disease Rapid Diagnostic Testing Market (by Application), 2019 Vs. 2025, $Million
Figure 7:    Global Infectious Disease Rapid Diagnostic Testing Market (by End User),  2019 Vs. 2025, $Million
Figure 8:    Global Infectious Disease Rapid Diagnostic Testing Market Snapshot
Figure 2.1:    Global Infectious Disease Rapid Diagnostic Testing Market Segmentation
Figure 4.1:    Comparison Between Commercially Available Infectious Disease RDT Products Vs. Laboratory Testing
Figure 4.2:    Global Infectious Disease Rapid Diagnostic Market (by Infectious Disease), Pre-COVID-19 Vs. Post-COVID-19
Figure 4.3:    Global Infectious Disease Rapid Diagnostic Testing Market, $Million,  2019-2025
Figure 4.4:    Major Factors Considered
Figure 5.1:    New Cases of Respiratory and Enteric Infections, Globally, 2012-2017
Figure 5.2:    Time of Infectious Disease Pandemics
Figure 6.1:    Global Infectious Disease Rapid Diagnostic Testing Market (by Product), 2019-2025
Figure 6.2:    Global Infectious Disease Rapid Diagnostic Market (by Assays), 2019-2025
Figure 6.3:    Global Infectious Disease Rapid Diagnostic Market (Platforms), 2019-2025
Figure 7.1:    Global Infectious Disease Rapid Diagnostic Testing Market (by Technology), 2019-2025
Figure 7.2:    Global Infectious Disease Rapid Diagnostic Market (RT-PCR), 2019-2025
Figure 7.3:    Global Infectious Disease Rapid Diagnostic Market (by INAAT), 2019-2025
Figure 7.4:    Global Infectious Disease Rapid Diagnostic Market (LFIA), 2019-2025
Figure 7.5:    Global Infectious Disease Rapid Diagnostic Market (EIA), 2019-2025
Figure 7.6:    Global Infectious Disease Rapid Diagnostic Market (Others), 2019-2025
Figure 8.1:    Global Infectious Disease Rapid Diagnostic Testing Market (by Application), 2019-2025
Figure 8.2:    Global Infectious Disease Rapid Diagnostic Market (Respiratory Infection), 2019-2025
Figure 8.3:    Global Infectious Disease Rapid Diagnostic Market (Gastro-Intestinal Infection), 2019-2025
Figure 8.4:    Global Infectious Disease Rapid Diagnostic Market (Center Nervous System Infection), 2019-2025
Figure 8.5:    Global Infectious Disease Rapid Diagnostic Market (Hospital-Acquired Infection), 2019-2025
Figure 8.6:    Global Infectious Disease Rapid Diagnostic Market (Sexually Transmitted Infections), 2019-2025
Figure 8.7:    Global Infectious Disease Rapid Diagnostic Market (Other Applications), 2019-2025
Figure 9.1:    Global Infectious Disease Rapid Diagnostic Testing Market (by Disease), 2019 and 2025
Figure 9.2:    Global Infectious Disease Rapid Diagnostic Market (by Bacterial Infection), 2019-2025
Figure 9.3:    Global Infectious Disease Rapid Diagnostic Market for Hospital Acquired Infection, 2019-2025
Figure 9.4:    Global Infectious Disease Rapid Diagnostic Market for Tuberculosis,  2019-2025
Figure 9.5:    Global Infectious Disease Rapid Diagnostic Market for CT/NG, 2019-2025
Figure 9.6:    Global Infectious Disease Rapid Diagnostic Market for Other Bacterial Infections, 2019-2025
Figure 9.7:    Global Infectious Disease Rapid Diagnostic Market (by Viral Infection), 2019-2025
Figure 9.8:    Global Infectious Disease Rapid Diagnostic Market Y-o-Y (by Viral Infection), 2019-2025
Figure 9.9:    Global Infectious Disease Rapid Diagnostic Market for Influenza, 2019-2025
Figure 9.10:    Global Infectious Disease Rapid Diagnostic Market for Hepatitis, 2019-2025
Figure 9.11:    Global Infectious Disease Rapid Diagnostic Market for HIV-AIDS, 2019-2025
Figure 9.12:    Global Infectious Disease Rapid Diagnostic Market for HPV, 2019-2025
Figure 9.13:    Global Infectious Disease Rapid Diagnostic Market for Other Viral Infections, 2019-2025
Figure 9.14:    Global Infectious Disease Rapid Diagnostic Market for Other Infections, 2019-2025
Figure 11.1:    Global Infectious Disease Rapid Diagnostic Testing Market (by Region), 2020 and 2025
Figure 11.2:    Global Infectious Disease Rapid Diagnostic Testing Market (by Region), 2019-2025
Figure 11.3:    Number of Confirmed COVID-19 Cases in Severely Affected Countries, as of April 8, 2020
Figure 11.4:    Global Infectious Disease Rapid Diagnostic Testing Market Share  (by Region), 2019 and 2025
Figure 11.5:    North America Infectious Disease Rapid Diagnostic Testing Market,  2019-2025
Figure 11.6:    North America Infectious Disease Rapid Diagnostic Testing Market (by Country), 2019-2025
Figure 11.7:    North America: Market Dynamics
Figure 11.8:    U.S. Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.9:    Month-Wise COVID-19 Cases, the U.S., as of April 8, 2020
Figure 11.10:    Canada Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.11:    Month-Wise COVID-19 Cases, Canada, as of April 8, 2020
Figure 11.12:    Europe Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.13:    Europe: Market Dynamics
Figure 11.14:    Europe Rapid Infectious Disease Diagnostic Testing Market (by Country),  2019-2025
Figure 11.15:    Germany Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.16:    Month-Wise COVID-19 Cases, Germany, as of April 8, 2020
Figure 11.17:    U.K. Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.18:    Month-Wise COVID-19 Cases, the U.K., as of April 8, 2020
Figure 11.19:    France Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.20:    Month-Wise COVID-19 Cases, France, as of April 8, 2020
Figure 11.21:    Italy Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.22:    Month-Wise COVID-19 Cases, Italy, as of April 8, 2020
Figure 11.23:    Spain Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.24:    Month-Wide COVID-19 Cases, Spain, as of April 8, 2020
Figure 11.25:    Russia Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.26:    Month-Wise COVID-19 Cases, Russia, as of April 8, 2020
Figure 11.27:    Rest-of-Europe Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.28:    APAC Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.29:    APAC: Market Dynamics
Figure 11.30:    APAC Infectious Disease Rapid Diagnostic Testing Market (by Country),  2019-2025
Figure 11.31:    China Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.32:    Month-Wise COVID-19 Cases, China, as of April 8, 2020
Figure 11.33:    Japan Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.34:    Month-Wise COVID-19 Cases, Japan, as of April 8, 2020
Figure 11.35:    India Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.36:    Month-Wise COVID-19 Cases, India, as of April 8, 2020
Figure 11.37:    Taiwan Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.38:    Month-Wise COVID-19 Cases, Taiwan, as of April 8, 2020
Figure 11.39:    South Korea Infectious Disease Rapid Diagnostic Testing Market,  2019-2025
Figure 11.40:    Month-Wise COVID-19 Cases, South Korea, as of April 8, 2020
Figure 11.41:    Singapore Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.42:    Month-Wise COVID-19 Cases, Singapore, as of April 8, 2020
Figure 11.43:    Australia Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.44:    Month-Wise COVID-19 Cases, Australia, as of April 8, 2020
Figure 11.45:    Rest-of-APAC Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.46:    Latin America Infectious Disease Rapid Diagnostic Testing Market,  2019-2025
Figure 11.47:    Latin America: Market Dynamics
Figure 11.48:    Latin America Infectious Disease Rapid Diagnostic Testing Market (by Country), 2019-2025
Figure 11.49:    Brazil Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.50:    Month-Wise COVID-19 Cases, Brazil, as of April 8, 2020
Figure 11.51:    Mexico Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.52:    Month-Wise COVID-19 Cases, Australia, as of April 8, 2020
Figure 11.53:    Rest-of-Latin America Infectious Disease Rapid Diagnostic Testing Market,  2019-2025
Figure 11.54:    Middle East Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.55:    Month-Wise COVID-19 Cases, KSA & UAE, as of April 8, 2020
Figure 11.56:    Africa Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 11.57:    Month-Wise COVID-19 Cases, Egypt, Ethiopia, Nigeria, and Democratic Republic of Congo, as of April 8, 2020
Figure 11.58:    RoW Infectious Disease Rapid Diagnostic Testing Market, 2019-2025
Figure 12.1:    Global Infectious Disease Rapid Diagnostic Market (by End User)
Figure 12.2:    Global Infectious Disease Rapid Diagnostic Testing Market (by End User), 2019-2025
Figure 12.3:    Global Infectious Disease Rapid Diagnostic Testing Market (by Hospitals), 2019-2025
Figure 12.4:    Global Infectious Disease Rapid Diagnostic Testing Market (by Clinics), 2019-2025
Figure 12.5:    Global Infectious Disease Rapid Diagnostic Testing Market (by Diagnostic Centers), 2019-2025
Figure 12.6:    Global Infectious Disease Rapid Diagnostic Testing Market (by Other End Users), 2019-2025
Figure 13.1:    Share of Key Developments and Strategies, 2016–2020
Figure 13.2:    Product Approval Share (by Company), 2016 – 2020
Figure 13.3:    Product Launch and Upgradation Share (by Company), 2016 –2020
Figure 13.4:    Synergistic Activities Share (by Company), 2016 –2020
Figure 13.5:    Funding and Expansion Share (by Company), 2016 –2020
Figure 13.6:    Mergers and Acquisitions Share (by Company), 2016 –2020
Figure 13.7:    Market Share Analysis for the Global Infectious Disease Rapid Diagnostic Testing Market, 2019
Figure 13.8:    Growth Share Matrix for Global Infectious Disease Rapid Diagnostic Testing Market (by Company), 2019
Figure 13.9:    Growth Share Matrix for Global Infectious Disease Rapid Diagnostic Testing Market (by Application), 2019
Figure 13.10:    Growth Share Matrix for Global Infectious Disease Rapid Diagnostic Testing Market (by Technology), 2019
Figure 14.1:    Total Number of Companies Profiled
Figure 14.2:    Competitive Benchmarking of Abbott Laboratories
Figure 14.3:    Competitive Benchmarking of F. Hoffmann-La Roche Ltd
Figure 14.4:    Competitive Benchmarking of Danaher Corporation
Figure 14.5:    Competitive Benchmarking of Luminex Corporation
Figure 14.6:    Competitive Benchmarking of BGI Group
Figure 14.7:    Competitive Benchmarking of bioMerieux S.A.
Figure 14.8:    Competitive Benchmarking of DiaSorin S.p.A.
Figure 14.9:    Competitive Benchmarking of Hologic, Inc.
Figure 14.10:    Competitive Benchmarking of Mesa Biotech
Figure 14.11:    Competitive Benchmarking of Quidel Corporation
Figure 14.12:    Competitive Benchmarking of Thermo Fisher Scientific Inc.
Figure 14.13:    Competitive Benchmarking of GenMark Diagnostics
Figure 14.14:    Competitive Benchmarking of CTK Biotech
Figure 14.15:    Competitive Benchmarking of Becton, Dickinson and Company
Figure 14.16:    Competitive Benchmarking of Cellex